News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
IASLC welcomes Jennifer C. King as the new Chief Science Officer
Photo taken from IASLC/Twitter
Oct 29, 2023, 17:23

IASLC welcomes Jennifer C. King as the new Chief Science Officer

The International Association for the Study of Lung Cancer (IASLC) shared a post on Twitter:

“IASLC welcomes Jennifer C. King, as the new Chief Science Officer. Dr. King will drive scientific strategy, support research, and lead Scientific Affairs. ‘Her addition enhances our commitment to science and patient benefit,’ says Karen Kelly, CEO.”

For details click here.
Source: IASLC/Twitter
cancer IASLC Jennifer C. King Karen Kelly OncoDaily Oncology
Special Coverage
Voices
Aug 26, 2025, 17:21
Dinesh Pendharkar: Empowering the Last Mile
Blog Posts
Aug 26, 2025, 17:15
Amol Akhade: Junk Food and Cancer Risk
Insight
Aug 26, 2025, 17:09
Jeff Yang: More Proof That Cancer Screening Saves Lives
Voices
Aug 26, 2025, 16:55
Pezcoller Symposium Highlights 2025: Studying and Treating Cancer in the Digital Era - ESO
Blog Posts
Aug 26, 2025, 16:36
Michaela Boland: Seeking a Liver Donor with Support from URMC
Insight
Aug 26, 2025, 16:19
David J. Skorton: Supporting Biomedical Research Learners for Long-Term Success
Voices
Aug 26, 2025, 15:59
Children's Cancer Institute Identifies Potential New Treatment Strategy for High-Risk Neuroblastoma
Insight
Aug 26, 2025, 15:57
Yüksel Ürün Highlights an Eexcellent Review of AI Across the Cancer Care Continuum
Voices
Aug 26, 2025, 15:54
Cathy Eng Celebrates SU2C Nashville and Support for Cancer Research Grants
Voices
Aug 26, 2025, 15:51
Bogda Koczwara on Addressing Discordance Between Cancer Patients' Preferences and Treatment Goals
Insight
Aug 26, 2025, 15:47
Catherine Alix-Panabières: From Discovery to Diagnosis - A Perspective for Circulating Tumor Cells in Personalized Oncology
Insight
Aug 26, 2025, 15:45
Haystack MRD by Quest Diagnostics Received FDA Breakthrough Device Designation